Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
2014 · European Respiratory Journal · 300 citations
https://doi.org/10.1183/09031936.00188313
J
Jan‐Willem C. Alffenaar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
469
Papers
15.8K
Citations
60
h-index
288
i10-index
Jan‐Willem C. Alffenaar is an academic researcher from The University of Sydney. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Antibiotics Pharmacokinetics and Efficacy & Antifungal resistance and susceptibility. The author has an h-index of 60, co-authored 399 publications.
ORCID: 0000-0001-6703-0288Papers by this author
worksMDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
2020 · International Journal of Infectious Diseases · 224 citations
https://doi.org/10.1016/j.ijid.2020.01.042
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
2024 · The Lancet Infectious Diseases · 205 citations
https://doi.org/10.1016/s1473-3099(23)00731-4
Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention
2017 · Clinical Infectious Diseases · 187 citations
https://doi.org/10.1093/cid/cix992
Therapeutic Drug Monitoring of Posaconazole: an Update
2016 · Current Fungal Infection Reports · 171 citations
https://doi.org/10.1007/s12281-016-0255-4
Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies
2020 · npj Primary Care Respiratory Medicine · 114 citations
https://doi.org/10.1038/s41533-020-0179-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat